Medicare Part D Formulary Coverage of Disease-Modifying Therapies for Multiple Sclerosis

JAMA Health Forum 2026 Open access

Read full text
Authors: P Li, Matthew J. Klebanoff, John Kent Lin, Keya D. Doshi, Salim Chahin, Jalpa A. Doshi
DOI: 10.1001/jamahealthforum.2026.0871
Cited by: 1
References: 4

Abstract

This cohort study examines Medicare Part D formulary coverage of disease-modifying therapies for patients with multiple sclerosis, comparing coverage of brand-name and generic drugs.

Fields of Study & Subjects

Pharmaceutical Economics and Policy Multiple Sclerosis Research Studies Health Systems Economic Evaluations Quality of Life

Publication details

Journal / source
JAMA Health Forum
Publisher
American Medical Association (AMA)
Volume
7
Issue
4
Pages
e260871–e260871
Publication date
24 April 2026
Language
EN